Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ 242,408
▼ 44% vs 2024
Profit
Caution€ -1.1 million
▲ 31% vs 2024
Debts
Low€ 1.3 million
▲ 9% vs 2024
Minoryx Therapeutics BE from Charleroi, company number BE0713984534, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year Minoryx Therapeutics BE recorded a gross margin of € 242,408 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € -1.6 million to € -1.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
What happened at Minoryx Therapeutics BE?
What happened at Minoryx Therapeutics BE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Minoryx Therapeutics SL stepped down as director. NBB
- Marc Martinell Pedemonte stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- New establishment in Charleroi. KBO
- Minoryx Therapeutics SL became a director. NBB
- Marc Martinell Pedemonte became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.4 million loss in 2021 to € 1.1 million loss in 2025.
Paid € 8 in corporate taxes since 2021.
On average € 50,500 of value added per employee in 2025.
A new publication or filing at Minoryx Therapeutics BE? We notify you, reason included.
Follow Minoryx Therapeutics BENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Khalid Islam
since 2018 · until 2030
Marc Martinell Pedemonte
Director
since 2018 · until 2030
Establishments
Establishment units
Physical locations of this company
Avenue Jean Mermoz 32 box 6
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0713.984.534
- VAT number
- BE 0713.984.534
- Registered office
- Avenue Jean Mermoz 32 bus 6, 6041 Charleroi
- Names & denominations
- Minoryx Therapeutics BE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 2018
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige technische testen en toetsen
Vervaardiging van farmaceutische grondstoffen
Overige gespecialiseerde wetenschappelijke en technische activiteiten